Skip to main content
PMC home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 1998 Nov;55(11):742–749. doi: 10.1136/oem.55.11.742

Immunological markers among workers exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin

W Halperin, R Vogt, M H Sweeney, G Shopp, M Fingerhut, M Petersen
PMCID: PMC1757534  PMID: 9924450

Abstract

OBJECTIVES: To examine the association of immune cell number and function with occupational exposure to substances contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). METHODS: A cross sectional medical survey. The exposed participants were employed at two chemical plants between 1951 and 1972 in the manufacture of 2,4,5- trichlorophenate and its derivatives. The reference group consisted of people with no occupational exposure to phenoxy herbicides who lived within the communities of the workers. Data from a total of 259 workers and 243 unexposed referents were included in the analysis of immune function. Laboratory tests for immune status included enumeration of circulating leukocyte and lymphocyte populations, proliferative responses of circulating lymphocytes to mitogens and antigens, and serum concentrations of the major immunoglobulins and complement factor C3. RESULTS: The workers had substantial exposure to substances contaminated with TCDD, as indicated by a lipid adjusted mean serum TCDD concentration of 229 ppt compared with a mean of 6 ppt in the unexposed referents. Workers were divided into categories based on their serum TCDD concentration. For all categories except the lowest, with values of serum TCDD comparable with the unexposed referents, there were increased odds of having lower counts of CD26 cells (activated T cells) (odds ratio (OR) 1.0, 95% confidence interval (95% CI) 0.5 to 1.8 for TCDD < 20 ppt; OR 1.6, 95% CI 0.8 to 3.2 for TCDD 20- 51 ppt; OR 2.7, 95% CI 1.4 to 5.1 for TCDD 52-125 ppt; OR 2.6, 95% CI 1.4 to 4.9 for TCDD 125-297 ppt; OR 2.4, 95% CI 1.3 to 4.6 for TCDD 298- 3389 ppt). A less consistent finding was decreased spontaneous proliferation of cultured lymphocytes. However, increases were found in proliferation of lymphocytes in response to concanavalin and pokeweed in workers in the high TCDD category. Age, cigarette smoking, and alcohol were significant predictors of several immunological outcomes. CONCLUSIONS: Associations between serum TCDD concentration and both a decrease in circulating CD26 cells and decreased spontaneous background proliferation were the major findings of this study. These results are unlikely to be of clinical importance but may reflect limited evidence for an association between immunological changes in workers and high serum concentrations of TCDD, or chance findings resulting from the evaluation of multiple immunological variables.

 

Full Text

The Full Text of this article is available as a PDF (139.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banez E. I. Hematologic response to acute inflammation: the band neutrophil revisited. Tex Med. 1990 Apr;86(4):26–28. [PubMed] [Google Scholar]
  2. Dang N. H., Hafler D. A., Schlossman S. F., Breitmeyer J. B. FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation. Cell Immunol. 1990 Jan;125(1):42–57. doi: 10.1016/0008-8749(90)90061-u. [DOI] [PubMed] [Google Scholar]
  3. Edwards B. S., Merritt J. A., Jelen P. A., Borden E. C. Effects of diethyldithiocarbamate, an inhibitor of interferon antiviral activity, upon human natural killer cells. J Immunol. 1984 Jun;132(6):2868–2875. [PubMed] [Google Scholar]
  4. Evans R. G., Webb K. B., Knutsen A. P., Roodman S. T., Roberts D. W., Bagby J. R., Garrett W. A., Jr, Andrews J. S., Jr A medical follow-up of the health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Environ Health. 1988 Jul-Aug;43(4):273–278. doi: 10.1080/00039896.1988.10545949. [DOI] [PubMed] [Google Scholar]
  5. Fingerhut M. A., Halperin W. E., Marlow D. A., Piacitelli L. A., Honchar P. A., Sweeney M. H., Greife A. L., Dill P. A., Steenland K., Suruda A. J. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med. 1991 Jan 24;324(4):212–218. doi: 10.1056/NEJM199101243240402. [DOI] [PubMed] [Google Scholar]
  6. Halperin W., Kalow W., Sweeney M. H., Tang B. K., Fingerhut M., Timpkins B., Wille K. Induction of P-450 in workers exposed to dioxin. Occup Environ Med. 1995 Feb;52(2):86–91. doi: 10.1136/oem.52.2.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hoffman R. E., Stehr-Green P. A., Webb K. B., Evans R. G., Knutsen A. P., Schramm W. F., Staake J. L., Gibson B. B., Steinberg K. K. Health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. JAMA. 1986 Apr 18;255(15):2031–2038. [PubMed] [Google Scholar]
  8. Holsapple M. P., Snyder N. K., Wood S. C., Morris D. L. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology. 1991;69(3):219–255. doi: 10.1016/0300-483x(91)90184-3. [DOI] [PubMed] [Google Scholar]
  9. Jennings A. M., Wild G., Ward J. D., Ward A. M. Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Br J Ind Med. 1988 Oct;45(10):701–704. doi: 10.1136/oem.45.10.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Luster M. I., Ackermann M. F., Germolec D. R., Rosenthal G. J. Perturbations of the immune system by xenobiotics. Environ Health Perspect. 1989 May;81:157–162. doi: 10.1289/ehp.8981157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mattern T., Scholz W., Feller A. C., Flad H. D., Ulmer A. J. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes. Scand J Immunol. 1991 Jun;33(6):737–748. doi: 10.1111/j.1365-3083.1991.tb02548.x. [DOI] [PubMed] [Google Scholar]
  12. Mocarelli P., Marocchi A., Brambilla P., Gerthoux P., Young D. S., Mantel N. Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA. 1986 Nov 21;256(19):2687–2695. [PubMed] [Google Scholar]
  13. Neubert R., Maskow L., Webb J., Jacob-Müller U., Nogueira A. C., Delgado I., Helge H., Neubert D. Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system. 1. Blood cell receptors in volunteers with moderately increased body burdens. Life Sci. 1993;53(26):1995–2006. doi: 10.1016/0024-3205(93)90021-t. [DOI] [PubMed] [Google Scholar]
  14. Ott M. G., Zober A., Germann C. Laboratory results for selected target organs in 138 individuals occupationally exposed to TCDD. Chemosphere. 1994 Nov-Dec;29(9-11):2423–2437. doi: 10.1016/0045-6535(94)90411-1. [DOI] [PubMed] [Google Scholar]
  15. Patterson D. G., Jr, Fingerhut M. A., Roberts D. W., Needham L. L., Sweeney M. H., Marlow D. A., Andrews J. S., Jr, Halperin W. E. Levels of polychlorinated dibenzo-p-dioxins and dibenzofurans in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Ind Med. 1989;16(2):135–146. doi: 10.1002/ajim.4700160205. [DOI] [PubMed] [Google Scholar]
  16. Tucker A. N., Vore S. J., Luster M. I. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol. 1986 Apr;29(4):372–377. [PubMed] [Google Scholar]
  17. Webb K. B., Evans R. G., Knutsen A. P., Roodman S. T., Roberts D. W., Schramm W. F., Gibson B. B., Andrews J. S., Jr, Needham L. L., Patterson D. G. Medical evaluation of subjects with known body levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Toxicol Environ Health. 1989;28(2):183–193. doi: 10.1080/15287398909531339. [DOI] [PubMed] [Google Scholar]
  18. White K. L., Jr, Lysy H. H., McCay J. A., Anderson A. C. Modulation of serum complement levels following exposure to polychlorinated dibenzo-p-dioxins. Toxicol Appl Pharmacol. 1986 Jun 30;84(2):209–219. doi: 10.1016/0041-008x(86)90128-6. [DOI] [PubMed] [Google Scholar]
  19. Zober M. A., Ott M. G., Päpke O., Senft K., Germann C. Morbidity study of extruder personnel with potential exposure to brominated dioxins and furans. I. Results of blood monitoring and immunological tests. Br J Ind Med. 1992 Aug;49(8):532–544. doi: 10.1136/oem.49.8.532. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES